Gene Test Estimates 5yr Risk Of Recurrence For Breast Cancer Patients, Says Studies
Positive Results from Two Studies of the PAM50-Based In Vitro Diagnostic Assay will be Presented at the Annual IMPAKT Breast Cancer Conference NanoString Technologies, Inc...